Your fact-checks will appear here
The topic is about the biological pathway that explains why some overdoses produce severe neurologic injury.
No explicit pharmacovigilance case reports documenting confirmed drug–drug interactions between (antiemetics, growth factors, or antibiotics) are identified in the provided reporting; instead, the lit...
Suspected ivermectin neurotoxicity is managed primarily with supportive care, close neurologic monitoring, and targeted interventions guided by toxicology consultation because no proven clinical antid...
Short answer: yes—an overdose of can cause serious acute neurological and systemic harm, and there are credible reports and mechanistic reasons to expect some individuals may experience persistent or ...
P‑glycoprotein (P‑gp, ABCB1/MDR1) at the blood–brain barrier is the primary efflux transporter that prevents ivermectin from accumulating in the central nervous system by actively pumping the drug bac...
Yes — evidence from laboratory studies, pharmacology reviews and post‑marketing case series shows a plausible and documented risk that ivermectin’s CNS effects and its interactions with drug‑transport...